Tacrovera 0.03% Lotion Information
Tacrovera 0.03% Lotion is a commercial drug that is prescribed in the form of Lotion. Primarily, it is used for the treatment of Liver transplant, Kidney transplant, Heart Transplant. Tacrovera 0.03% Lotion also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Tacrovera 0.03% Lotion. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Some other side effects of Tacrovera 0.03% Lotion have been listed ahead. Usually, these side effects of Tacrovera 0.03% Lotion go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Tacrovera 0.03% Lotion has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Tacrovera 0.03% Lotion's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Infections, Diabetes Type 2 must refrain from the use of Tacrovera 0.03% Lotion since this can cause severe adverse effects. Some other conditions that can be affected by Tacrovera 0.03% Lotion are listed in the contraindications section below.
Drug interactions for Tacrovera 0.03% Lotion have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Tacrovera 0.03% Lotion is safe while driving, and is is addictive in nature.
Tacrovera 0.03% Lotion Benefits & Uses
Tacrovera 0.03% Lotion is used to treat the following -
Main Benefits
- Liver transplant
- Kidney transplant
- Heart Transplant
Other Benefits
Tacrovera 0.03% Lotion Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Tacrovera 0.03% Lotion Side Effects
Based on research, the following side effects have been observed when Tacrovera 0.03% Lotion is used -
Moderate
- Renal Impairment
- Depression (Read More - From Meditation to Nutrition: Home Remedies for Easing Depression)
- Diabetes (Read More - 10 Home Remedies for Diabetes)
- Skin redness
- Skin irritation
- Skin Infection
Mild
Tacrovera 0.03% Lotion Related Warnings
-
Is the use of Tacrovera 0.03% Lotion safe for pregnant women?
Tacrovera can have harmful effects in pregnant women. If you experience any discomfort after using Tacrovera, then discontinue the use and take your doctor's advice.
Moderate -
Is the use of Tacrovera 0.03% Lotion safe during breastfeeding?
Tacrovera can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
Moderate -
What is the effect of Tacrovera 0.03% Lotion on the Kidneys?
Tacrovera can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
Moderate -
What is the effect of Tacrovera 0.03% Lotion on the Liver?
The liver can be affected by Tacrovera. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Tacrovera only after medical advice.
Moderate -
What is the effect of Tacrovera 0.03% Lotion on the Heart?
Use of Tacrovera may be dangerous for the heart. Do not use it without doctor's advice.
Severe
Severe Interaction of Tacrovera 0.03% Lotion with Other Drugs
Tacrovera 0.03% Lotion should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Tacrovera 0.03% Lotion Contraindications
If you are suffering from any of the following diseases, you should not take Tacrovera 0.03% Lotion unless your doctor advises you to do so -
- Infections
- High Blood Pressure
- Hyperkalemia
- Diabetes Type 2
- Liver Disease
- Hyperthermia
Frequently asked Questions about Tacrovera 0.03% Lotion
-
Is this Tacrovera 0.03% Lotion habit forming or addictive?
No, you will not get addicted to Tacrovera 0.03% Lotion.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Tacrovera 0.03% Lotion as it does not make you drowsy.
Safe -
Is it safe?
Yes, but take Tacrovera 0.03% Lotion only as per medical advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
Tacrovera 0.03% Lotion is unable to treat or cure mental disorders.
No
Tacrovera 0.03% Lotion Interactions with Food and Alcohol
-
Interaction between Food and Tacrovera 0.03% Lotion
Due to a lack of research, nothing can be said about the consequences of taking Tacrovera 0.03% Lotion together with food.
Unknown -
Interaction between Alcohol and Tacrovera 0.03% Lotion
Taking alcohol with Tacrovera 0.03% Lotion can be dangerous.
Severe
See all substitutes for Tacrovera
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
